Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.

Published on Apr 1, 2020in Laryngoscope2.465
· DOI :10.1002/LARY.28202
Ester Orlandi22
Estimated H-index: 22
(University of Milan),
Stefano Cavalieri8
Estimated H-index: 8
(University of Milan)
+ 18 AuthorsPaolo Bossi39
Estimated H-index: 39
(University of Brescia)
Sources
Abstract
OBJECTIVE: Outcomes of locally advanced epithelial sinonasal cancers remain unsatisfactory; moreover, only limited and heterogeneous data exist on prognostic factors. METHODS: We reviewed all consecutive patients with American Joint Committee Cancer stage III to IV epithelial sinonasal cancers treated with platinum-based induction chemotherapy (IC) followed by locoregional treatment between 1996 and 2015. RESULTS: We identified 69 patients treated with a multimodal approach (IC, surgery, radiotherapy). Overall, 44 patients recurred (64%). Of those, 19 patients received salvage surgery, but only four remained disease-free. Median overall survival (OS) was 62.5 months. Sinonasal neuroendocrine and small cell histotypes (P = 0.0085), neuroendocrine differentiation (P = 0.006), and lack of response to IC (P = 0.03) were associated with worse OS. In patients who recurred, median OS was 13 months since recurrence. Survival was longer in patients submitted to salvage surgery (44%) than in those receiving chemotherapy alone at recurrence (29.5 vs. 4.6 months). Patients with a clinical benefit after palliative chemotherapy had a longer median OS than those with disease progression (29.2 vs. 4.4 months; P < 0.0001). CONCLUSION: Globally, the prognosis of locally advanced epithelial sinonasal cancers is dismal, with worse outcomes for neuroendocrine lesions. In the recurrent setting, feasibility of salvage surgery and clinical benefit from palliative chemotherapy are associated with longer OS. A multimodal treatment strategy with IC seems to offer improved OS when compared with other retrospective series not employing such a therapeutic tool. LEVEL OF EVIDENCE: 4 Laryngoscope, 2019.
References44
Newest
#1Tawfiq Khoury (Duke University)H-Index: 3
#2David W. Jang (Duke University)H-Index: 12
Last. Ralph Abi Hachem (Duke University)H-Index: 8
view all 6 authors...
BACKGROUND: Cancers of the paranasal sinuses are rare tumors that tend to be aggressive and usually are diagnosed at an advanced stage. Despite being rare, these tumors include a wide spectrum of histological subtypes with different biological behaviors. Choosing the optimal treatment modalities and analyzing the different oncological outcomes is therefore challenging. This study aims to evaluate the role of induction chemotherapy prior to definitive local therapy for sinonasal malignancies. MET...
12 CitationsSource
#1Moran Amit (Houston Methodist Hospital)H-Index: 29
#2Ahmed S. Abdelmeguid (University of Texas MD Anderson Cancer Center)H-Index: 6
Last. Ehab Y. Hanna (University of Texas MD Anderson Cancer Center)H-Index: 62
view all 14 authors...
PURPOSEMultimodal therapy is a well-established approach for the treatment of sinonasal undifferentiated carcinoma (SNUC); however, the optimal sequence of the various treatments modalities is yet to be determined. This study aimed to assess the role of induction chemotherapy (IC) in guiding definitive therapy in patients with SNUC.METHODSNinety-five previously untreated patients diagnosed with SNUC and treated between 2001 and 2018 at The University of Texas MD Anderson Cancer Center were inclu...
25 CitationsSource
#1Mauricio E. Gamez (Mayo Clinic)H-Index: 10
#2Devyani Lal (Mayo Clinic)H-Index: 19
Last. Samir H. Patel (Mayo Clinic)H-Index: 16
view all 9 authors...
Background Sinonasal undifferentiated carcinoma (SNUC) is a rare aggressive disease arising in the nasal cavity and paranasal sinuses with poor prognosis and unclear optimal management. Methods Forty patients were analyzed. Nasal cavity was the most common primary site. Most patients presented with T4 disease, received trimodality therapy, and were treated with intensity-modulated radiotherapy (IMRT). Results Median follow-up was 6.9 years. Sixteen patients (40%) experienced recurrent disease, 5...
15 CitationsSource
#1Arnaud Paré (University of Paris-Sud)H-Index: 3
#1Arnaud Paré (University of Paris-Sud)H-Index: 3
Last. Antoine Moya Plana (University of Paris-Sud)H-Index: 3
view all 12 authors...
Abstract Background Poor prognosis of sinonasal cancers (SNC) is usually due to the non-specific symptoms leading to late diagnosis with locally advanced disease . However, previous prognostic studies were often based on heterogeneous cohorts because of the scarcity of SNC. With squamous cell carcinoma being the main histological subgroup, the study aimed to perform a prognostic analysis on sinonasal squamous cell carcinoma (SNSCC) particularly, and to evaluate the oncological results of a multi...
17 CitationsSource
#1Robert S. Benjamin (University of Texas MD Anderson Cancer Center)H-Index: 96
The article by Savina et al. from the large METASARC database of the French Sarcoma Group (BMC Med 15:78, 2017) provides a wealth of information about the natural history and therapy of patients with metastatic soft tissue sarcomas. The information complements – and in some cases surpasses – that obtained from randomized clinical trials, and should not be overlooked because of its retrospective nature. For rare diseases, retrospective data are often more important than data from randomized trial...
3 CitationsSource
Abstract Re-irradiation has been increasingly offered as a potential effective treatment for head and neck squamous cell carcinoma (HNSCC) loco-regional recurrence as well as second primary tumor in previously irradiated area. This review focused on the role of postoperative re-irradiation (POreRT) in terms of feasibility, toxicity and long-term outcomes in HNSCC patients. The key issue for the research was formulated in two questions according to the PICO (population, intervention, control, and...
9 CitationsSource
#1Tom P. van der Laan (UG: University of Groningen)H-Index: 5
#2René S Iepsma (UMCG: University Medical Center Groningen)H-Index: 1
Last. Gyorgy B. Halmos (UMCG: University Medical Center Groningen)H-Index: 19
view all 6 authors...
Abstract The aim of this meta-analysis was to provide treatment guidelines for sinonasal neuroendocrine carcinoma (SNC) by combining all available data in the literature. A literature search for all studies concerning SNC was performed against the MEDLINE and EMBASE databases. Available clinical data was normalized, pooled, and statistically analyzed. A total of 701 cases of SNC were available for analysis, comprising 127 well or moderately differentiated sinonasal neuroendocrine carcinomas (SNE...
24 CitationsSource
Abstract An extremely large variety of benign and malignant tumours occur at skull base; these tumour lesions are in the proximity to structures deputed to relevant physiologic functions, limiting extensive surgical approaches to this body district. Most recent progresses of surgery and radiotherapy have allowed to improve local control with acceptable rates of side effects. Various photon radiotherapy techniques are employed, including 3-dimensional conformal radiotherapy, intensity modulated r...
25 CitationsSource
Background Indications for preservation of orbital contents in case of malignant sinonasal tumors invading the orbit remain controversial. Methods A retrospective consecutive review was conducted of patients in a tertiary care center over a 15-year period. Results Ninety-three patients were diagnosed with a malignant tumor invading the orbit. Eighty-three were treated with curative intent of which 58 underwent surgery. Mean follow-up was 45 months. Orbital preservation was feasible in 66% of cas...
15 CitationsSource
#1Vasileios Askoxylakis (DKFZ: German Cancer Research Center)H-Index: 23
#2Pia Hegenbarth (DKFZ: German Cancer Research Center)H-Index: 1
Last. Peter E. Huber (DKFZ: German Cancer Research Center)H-Index: 65
view all 7 authors...
Background Radiotherapy has a central role in the treatment of sinonasal malignancies, either as postoperative or as primary therapy. To study the efficacy and safety of intensity modulated radiotherapy (IMRT) for sinonasal tumors a single center retrospective evaluation focusing on survival and therapy related toxicity was performed.
23 CitationsSource
Cited By6
Newest
Sinonasal squamous cell carcinoma is a rare tumor affecting the nasal cavity and paranasal sinuses. Several aspects of this disease, ranging from epidemiology to biology, pathology, diagnosis, staging, treatment, and post-treatment surveillance are controversial, and consensus on how to manage this sinonasal cancer is lacking. A narrative literature review was performed to summarize the current evidence and provide the reader with available data supporting the decision-making process in patients...
Source
Purpose: We report the outcome of a mono-institutional retrospective study of sinonasal carcinoma with the primary focus on GTV (gross tumor volume) and the effect of radiotherapy. Methods: 53 patients with sinonasal carcinoma and that of the nasal cavity, paranasal sinus or both except lymphoma were included. All patients were treated between 1999 and 2017. For tumor volume delineation, all pre-therapeutic images were fused to the planning CT (computed tomography). Results: The median follow-up...
Source
#1Marco Ferrari (University of Brescia)H-Index: 100
#2Ester OrlandiH-Index: 22
Last. Paolo BossiH-Index: 39
view all 3 authors...
PURPOSE OF REVIEW The present review provides the reader with the state-of-the-art concepts of sinonasal oncology in view of the latest literature data. RECENT FINDINGS Most recent publications in sinonasal oncology assessed treatment timing, centralization, surgical approach, margin status, orbit/neck management, salvage strategies, emerging surgical technologies, intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), particle radiotherapy, and neoadjuvant chemot...
Source
#1Brandon M. Lehrich (UCI: University of California, Irvine)H-Index: 6
#2Tyler M. Yasaka (UCI: University of California, Irvine)H-Index: 2
Last. Edward C. Kuan (UCI: University of California, Irvine)H-Index: 14
view all 4 authors...
OBJECTIVES/HYPOTHESIS There exists a lack of consensus on the optimal sequence of treatment for many sinonasal malignancies (SNMs). This study compares the overall survival (OS) outcomes for primary surgery (PS) versus salvage surgery (SS) in SNM patients across stage, histology, and primary site. STUDY DESIGN Retrospective database review. METHODS The National Cancer Database was queried for all SNM cases treated with multimodal surgical and nonsurgical therapy between 2004 and 2015. Logistic r...
1 CitationsSource
#1Jacky T. YeungH-Index: 9
Last. Charles TeoH-Index: 24
view all 5 authors...
Abstract Introduction The role of surgery is not well defined in locally advanced sinonasal cancers with intracranial involvement after all medical options have been exhausted. We hypothesize that patients whose tumours are deemed unresectable and referred to palliative care may benefit from radical salvage surgery. Methods We performed a single-center retrospective review of patients with malignant, locally advanced (Stage T4b) sinonasal cancers with intracranial involvement from 2000 to 2020, ...
Source
#1Cristiana BergaminiH-Index: 20
#2Stefano CavalieriH-Index: 8
Last. Lisa Licitra (University of Milan)H-Index: 67
view all 11 authors...
Introduction:Transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) are established procedures for treating hepatocellular cancer and selected malignancies with liver metastasis. ...
Source
#1Paolo Bossi (University of Brescia)H-Index: 39
#2Mario HermsenH-Index: 25
Last. Alessandro Franchi (UniPi: University of Pisa)H-Index: 53
view all 4 authors...
Source
#1Mario Hermsen (International Sleep Products Association)H-Index: 25
#2Cristina Riobello (International Sleep Products Association)H-Index: 6
Last. José Luis LlorenteH-Index: 28
view all 7 authors...
Abstract The sinonasal cavities harbor a wide variety of histologically distinct cancers, the majority very aggressive with 5-year survival rates between 30–60% and local recurrence as the main cause of death. This is a complex anatomic area, close to structures such the eyes and the brain, which is of special relevance for surgery and postoperative radiotherapy. The low incidence of these rare tumors hampers accumulation of experience with diagnosis and clinical managment as well as knowledge o...
5 CitationsSource